What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Alzheimer's disease
Dementia, Cognitive decline, Disease, Alzheimer's disease and Vascular dementia are his primary areas of study.
The concepts of his Dementia study are interwoven with issues in Psychiatry, Cognition, Apolipoprotein E and Gerontology.
His biological study spans a wide range of topics, including Global health, Obesity, Micronutrient and Confidence interval.
The various areas that Francesco Panza examines in his Cognitive decline study include Mediterranean diet, Endocrinology, Effects of sleep deprivation on cognitive performance and Polyunsaturated fatty acid.
The Disease study which covers Clinical trial that intersects with Monoclonal antibody, Family history, Placebo and Celecoxib.
His Alzheimer's disease study combines topics in areas such as Allele frequency, Genome-wide association study, Pharmacology and Late onset.
His most cited work include:
- Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease (2614 citations)
- Trends in adult body-mass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 19.2 million participants (2278 citations)
- Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults (2180 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Dementia, Disease, Internal medicine, Gerontology and Cognition.
His studies in Dementia integrate themes in fields like Alzheimer's disease, Longitudinal study and Psychiatry.
His Disease study combines topics from a wide range of disciplines, such as Genetics, Clinical trial, Bioinformatics and Epidemiology.
His Internal medicine research includes elements of Endocrinology, Oncology and Genotype.
His Gerontology research incorporates themes from Cognitive impairment and Confidence interval.
Francesco Panza combines subjects such as Presbycusis and Clinical psychology with his study of Cognition.
He most often published in these fields:
- Dementia (45.33%)
- Disease (30.74%)
- Internal medicine (27.82%)
What were the highlights of his more recent work (between 2017-2021)?
- Dementia (45.33%)
- Disease (30.74%)
- Cognition (19.26%)
In recent papers he was focusing on the following fields of study:
Francesco Panza focuses on Dementia, Disease, Cognition, Internal medicine and Gerontology.
His study in Dementia focuses on Vascular dementia in particular.
His Disease study incorporates themes from Clinical trial, Bioinformatics, Neuroscience and Monoclonal antibody.
His Cognition research is multidisciplinary, relying on both Presbycusis, Randomized controlled trial, Mediterranean diet, Micronutrient and Cognitive decline.
His study in Internal medicine is interdisciplinary in nature, drawing from both Cross-sectional study, Psychiatric status rating scales and Drug reaction.
Francesco Panza focuses mostly in the field of Gerontology, narrowing it down to topics relating to Biopsychosocial model and, in certain cases, Geriatric Depression Scale.
Between 2017 and 2021, his most popular works were:
- A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease. (228 citations)
- A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease. (228 citations)
- Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys (104 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Gene
His main research concerns Dementia, Disease, Cognition, Gerontology and Internal medicine.
His research integrates issues of Intervention, Biochemistry of Alzheimer's disease, Pathological and Neuroscience in his study of Dementia.
His Disease research integrates issues from Immunology, Clinical trial, Bioinformatics and Monoclonal antibody.
His work deals with themes such as Alzheimer's disease and Aβ oligomers, which intersect with Monoclonal antibody.
He has included themes like Geriatric Depression Scale, Longitudinal study and Vascular dementia in his Gerontology study.
The Internal medicine study combines topics in areas such as Psychiatric status rating scales and Genotype.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
